Benitec Biopharma Inc. share price logo

Benitec Biopharma Inc.

NASDAQ: BNTC

Small Cap

$12.15

+0.35

(+2.97%)

as on

Benitec Biopharma Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $11.87
    $12.33
    downward going graph

    2.30%

    Downside

    1.48%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.85
    $16.76
    downward going graph

    18.93%

    Downside

    37.94%

    Upside

    downward going graph

Benitec Biopharma Inc. share price movements today

Previous Close
$11.80
Open
$12.09
Volume
387.5K
Day's Low - High
$11.87 - $12.33
52 Week Low - High
$9.85 - $16.76

Benitec Biopharma Inc. Historical Returns

1 Month Return
+ 13.34 %
3 Month Return
+ 5.65 %
1 Year Return
-18.67 %
3 Year Return
+ 208.06 %
5 Year Return
-81.86 %

Benitec Biopharma Inc. Stock Fundamentals & Key Indicators

Check Benitec Biopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$416.5M

EPS (TTM)

-1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-46.5M

Revenue (TTM)

7.0K

Profit Margin

0.00%

Return On Equity TTM

-29.58%

Benitec Biopharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Benitec Biopharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Benitec Biopharma Inc. image
Benitec Biopharma Inc.
BUY$416.5M-81.86%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Benitec Biopharma Inc. Stock including INR - Dollar returns

The Benitec Biopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Benitec Biopharma Inc. investment value today

Current value as on today

₹88,586

Returns

-₹11,414

(-11.41%)

Returns from Benitec Biopharma Inc. Stock

-₹18,675 (-18.67%)

Dollar Impact

₹7,261 (+7.26%)

Analyst Recommendation on Benitec Biopharma Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Benitec Biopharma Inc.. Average target price of $25.8

Benitec Biopharma Inc. Share Price Target

Get share price movements and forecasts by analysts on Benitec Biopharma Inc..

What analysts predicted

52.91%UPSIDE

Target Price

$25.8

Current Price

$12.15

Analyzed by

7 Analysts

Target

$25.80

Benitec Biopharma Inc. target price $25.8, a slight upside of 52.91% compared to current price of $12.15. According to 7 analysts rating.

Indian Investors' Interest in Benitec Biopharma Inc. Stock

Search interest for Benitec Biopharma Inc. Stock has increased by 425% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:425% versus previous 30 day period

Benitec Biopharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
0
-
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-6
-4
-5
-5
-10
-15
-17
-9
-13
-13
EBITDA
-6
-4
-5
-5
-10
-15
-17
-9
-13
-13
Interest Expense
0
0
-
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-4
-4
-5
-9
-14
-16
-8
-11
-11
Income Tax Expense
0
-
0
-
-7
-
-
-
-
-
Net Income
-4
-2
-3
-3
-9
-14
-16
-8
-11
-11
Net Profit Margin
0.00%
-71316.67%
0.00%
0.00%
0.00%
0.00%
-2904.14%
0.00%
0.00%
0.00%

Benitec Biopharma Inc. Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
0
3
12
0
0
0
0
0
-
Gross Profit
0
0
0
5
0
0
0
0
0
0
Operating Income
-18
-12
-8
1
-8
-13
-17
-19
-22
-41
EBITDA
-21
-3
-6
1
-7
-13
-17
-18
-22
-41
Interest Expense
-
-
-
0
0
0
0
0
0
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-3
-8
3
-8
-13
-18
-19
-21
-37
Income Tax Expense
-9
-10
-4
0
0
0
0
0
0
-
Net Income
-10
-2
-4
1
-5
-10
-12
-13
-14
-37
Net Profit Margin
-5340.11%
-1708.71%
-143.03%
10.45%
-8529.90%
-23528.81%
-24942.47%
-26082.67%
-10069.91%
0.00%

Benitec Biopharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
-4
-5
-7
-9
-8
-8
-11
-11
Operating Cash Flow
-6
-3
-4
-7
-3
-8
-3
-3
-4
Investing Cash Flow
0
0
-
0
0
0
-
0
0
Financing Cash Flow
0
40
21
17
28
4
-
98
4
Change in Cash
-6
36
16
10
25
-5
-3
94
-4

Benitec Biopharma Inc. Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-4
-8
2
-8
-13
-18
-19
-21
-37
Operating Cash Flow
-8
-9
4
-7
-12
-15
-18
-19
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
7
8
0
1
22
16
16
68
70
Change in Cash
0
-1
4
-5
9
-15
-1
48
46

Global Institutional Holdings in Benitec Biopharma Inc.

Funds
Holdings
Ameriprise Financial Inc
0.93%
The Goldman Sachs Group Inc
0.63%
Franklin Resources Inc
6.92%
RA Capital Management, LLC
5.39%
Schonfeld Strategic Advisors LLC
0.76%
See all

Insights on Benitec Biopharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BNTC stock has moved up by 8.7%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BNTC has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 6.0K → 556.0K (in $), with an average increase of 98.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 36.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -8.96M → -11.93M (in $), with an average decrease of 16.4% per quarter

About Benitec Biopharma Inc.

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
OrganisationBenitec Biopharma Inc.
Headquarters3940 Trust Way, Hayward, CA, United States, 94545
IndustryBiotechnology
CEODr. Jerel A. Banks M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Benitec Biopharma Inc.

Name

Title

Dr. Jerel A. Banks M.D., Ph.D.

Executive Chairman & CEO

Ms. Megan Joan Boston B.Com., C.A.

CFO & Secretary

Ms. Sophie Mukadam

Chief Operating Officer

Dr. Michael Graham

Head of Discovery & Founding Scientist

Dr. Claudia Kloth Ph.D.

Senior Vice President of Manufacturing

FAQs

What is Benitec Biopharma Inc. share price today?

Benitec Biopharma Inc. share price today is $12.15 as on at the close of the market. Benitec Biopharma Inc. share today touched a day high of $12.33 and a low of $11.87.

What is the 52 week high and 52 week low for Benitec Biopharma Inc. share?

Benitec Biopharma Inc. share touched a 52 week high of $16.76 on and a 52 week low of $9.85 on . Benitec Biopharma Inc. stock price today i.e. is closed at $12.15,which is 27.51% down from its 52 week high and 23.35% up from its 52 week low.

What is Benitec Biopharma Inc.'s market capitalisation today?

Benitec Biopharma Inc. market capitalisation is $0.00T as on .

How to invest in Benitec Biopharma Inc. Stock (BNTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Benitec Biopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Benitec Biopharma Inc. Shares that will get you 0.1235 shares as per Benitec Biopharma Inc. share price of $12.15 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Benitec Biopharma Inc. Stock (BNTC) from India?

Indian investors can start investing in Benitec Biopharma Inc. (BNTC) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Benitec Biopharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Benitec Biopharma Inc. share’s latest price of $12.15 as on June 19, 2026 at 8:45 am IST, you will get 0.8230 shares of Benitec Biopharma Inc.. Learn more about fractional shares .

What are the returns that Benitec Biopharma Inc. has given to Indian investors in the last 5 years?

Benitec Biopharma Inc. stock has given -81.86% share price returns and 27.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?